
Kvrab D 30mg/20mg Capsule SR
Marketer
Kavita Pharma Chem
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Kvrab D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication, Kvrab D 30mg/20mg Sustained-Release Capsules. This treatment alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thereby easing discomfort. Kvrab D should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and potential worsening. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. However, report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; refrain from driving or activities requiring concentration until the medicine's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cool milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, or if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Kvrab D 30mg/20mg Capsule SR
No information provided. Therefore, no text can be rewritten.
Uses of Kvrab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Kvrab D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Kvrab D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Kvrab D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Kvrab D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule without chewing, crushing, or breaking it. Kvrab D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Kvrab D 30mg/20mg Capsule SR works:
Kvrab D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, working synergistically to alleviate digestive issues. Domperidone, a prokinetic agent, enhances gastric and intestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with Kvrab D 30mg/20mg sustained-release capsules. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Kvrab D 30mg/20mg capsules may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Kvrab D 30mg/20mg capsules are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Kvrab D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Kvrab D 30mg/20mg sustained-release capsules to individuals with impaired renal function. Dosage modification of Kvrab D 30mg/20mg sustained-release capsules might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use the extended-release Kvrab D 30mg/20mg capsules cautiously, potentially requiring dosage modification. Consult a physician before use. Kvrab D 30mg/20mg extended-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Kvrab D 30mg/20mg Capsule SR :
Should you forget a dose of Kvrab D 30mg/20mg SR Capsules, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kvrab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
